Cardlytics Inc. Stock News

Cardlytics (CDLX) delivered earnings and revenue surprises of 7.41% and 2.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ATLANTA, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its third quarter ended September 30, 2022 financi

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. InMed Pharmaceuticals Inc. (NASDAQ: INM)

Upgrades For World Wrestling Entertainment Inc (NYSE:WWE), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the second quarter, World Wrestling Enter had an EPS of $0.59

Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0 4 1 0 Last 30D 0

ATLANTA, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on September 1, 2022, Cardlytics’ Board of

The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500.

Analysts have provided the following ratings for Cardlytics (NASDAQ:CDLX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0 4 0 0 Last

CDLX earnings call for the period ending June 30, 2022.

Cardlytics, Inc. (NASDAQ:CDLX ) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Representatives Lynne Laube - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nic

Cardlytics (CDLX) delivered earnings and revenue surprises of -20.37% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ATLANTA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2022. Supplemental

Cardlytics (CDLX) delivered earnings and revenue surprises of -20.37% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysis offers insight from previous back-to-school seasons ahead of the second-largest shopping event of the year Analysis offers insight from previous back-to-school seasons ahead of the second-l

Independent investment bank and asset management firm Needham & Company, which specializes in financings for growth companies, has set a.